GILEAD SCIENCES, INC. $750,000,000 2.40% SENIOR NOTES DUE 2014 $700,000,000 3.05% SENIOR NOTES DUE 2016 $1,250,000,000 4.40% SENIOR NOTES DUE 2021 $1,000,000,000 5.65% SENIOR NOTES DUE 2041 Underwriting AgreementUnderwriting Agreement • December 8th, 2011 • Gilead Sciences Inc • Biological products, (no disgnostic substances) • New York
The Securities will be issued pursuant to an Indenture dated as of March 30, 2011 (the “Base Indenture”) between the Company and Wells Fargo Bank, National Association, as trustee (the “Trustee”), as supplemented by a supplemental indenture to be dated as of December 13, 2011 (together with the Base Indenture, the “Indenture”).
